Reply to: "Studies of macrophage therapy for cirrhosis - From mice to men"

Affiliations

¹ State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China; Department of Hepatobiliary Surgery, PLA Navy General Hospital, Beijing, China.
² State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China.
³ State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China. Electronic address: hyqin@fmmu.edu.cn.

Comment

Pengfei Ma et al. J Hepatol. 2018 May.

. 2018 May;68(5):1091-1093.

doi: 10.1016/j.jhep.2017.12.024. Epub 2018 Jan 6.

¹ State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China; Department of Hepatobiliary Surgery, PLA Navy General Hospital, Beijing, China.
² State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China.
³ State Key Laboratory of Cancer Biology, Department of Medical Genetics and Developmental Biology, Fourth Military Medical University, Xi'an, China. Electronic address: hyqin@fmmu.edu.cn.

No abstract available

Comment on

Cytotherapy with M1-polarized macrophages ameliorates liver fibrosis by modulating immune microenvironment in mice.
Ma PF, Gao CC, Yi J, Zhao JL, Liang SQ, Zhao Y, Ye YC, Bai J, Zheng QJ, Dou KF, Han H, Qin HY. Ma PF, et al. J Hepatol. 2017 Oct;67(4):770-779. doi: 10.1016/j.jhep.2017.05.022. Epub 2017 Jul 26. J Hepatol. 2017. PMID: 28596109
Studies of macrophage therapy for cirrhosis - From mice to men.
Thomas JA, Ramachandran P, Forbes SJ. Thomas JA, et al. J Hepatol. 2018 May;68(5):1090-1091. doi: 10.1016/j.jhep.2017.11.043. Epub 2018 Jan 6. J Hepatol. 2018. PMID: 29317297 No abstract available.